Zervogianni, Vanessa
Fletcher-Watson, Sue
Herrera, Gerardo
Goodwin, Matthew S.
Triquell, Elise
Pérez-Fuster, Patricia
Brosnan, Mark
Grynszpan, Ouriel http://orcid.org/0000-0002-7141-5946
Funding for this research was provided by:
International Foundation of Applied Disability Research (APa2016_026)
Orange (APa2016_026)
Union of European Football Associations (APa2016_026)
Ministerio de Ciencia, Innovación y Universidades (PID2019-105951RB-I00/AEI/10.13039/501100011033)
Universidad Autónoma de Madrid (PID2019-105951RB-I00/AEI/10.13039/501100011033)
Article History
Accepted: 12 April 2023
First Online: 11 May 2023
Declarations
:
: In exchange for scientific advisory board membership, Dr. Matthew Goodwin holds stock in Empatica, Inc., and Behavior Imaging Solutions, Inc. He also receives income from Janssen (the pharmaceutical division of Johnson & Johnson) for consulting on their JAKE data collection platform. Dr. Sue Fletcher-Watson contributed to creating an app ("FindMe") for autistic children, including an arrangement to receive royalties if sales exceeded an agreed threshold. However, this threshold was not exceeded, and the app is no longer available commercially. The other authors have no competing interests to declare relevant to this article's content.